BISACODYL SUPPOSITORIES

BISACODYL SUPPOSITORIES was reported 13068 times

BISACODYL SUPPOSITORIES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOKINETIC DYSARTHRIA 23 0.7667
1 VAGINAL FLATULENCE 187 0.6172
2 APPENDICOLITH 206 0.5323
3 ANTACID THERAPY 67 0.5154
4 SLEEP DISORDER THERAPY 101 0.5101
5 TOTAL LUNG CAPACITY INCREASED 102 0.3750
6 ANALGESIC THERAPY 98 0.3053
7 DRUG THERAPY 94 0.2773
8 CONGENITAL HIATUS HERNIA 61 0.2675
9 MALIGNANT MELANOMA STAGE 0 50 0.2392
10 ANTICOAGULANT THERAPY 64 0.2254
11 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
12 IVTH NERVE PARALYSIS 42 0.1772
13 VICTIM OF CHILD ABUSE 42 0.1673
14 BACTEROIDES INFECTION 41 0.1571
15 CEREBRAL HYPOPERFUSION 73 0.1567
16 EPIDURAL LIPOMATOSIS 52 0.1512
17 CHILD ABUSE 38 0.1467
18 CAPILLARITIS 37 0.1341
19 BINOCULAR EYE MOVEMENT DISORDER 35 0.1215
20 SEDATION COMPLICATION 304 0.1190
21 FEMALE GENITAL TRACT FISTULA 198 0.1159
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 107 0.1154
23 TOTAL LUNG CAPACITY ABNORMAL 42 0.1080
24 MULTIPLE DRUG THERAPY 79 0.1048
25 CEREBELLAR STROKE 35 0.0895
26 PULMONARY VASCULITIS 46 0.0855
27 RADICULOPATHY 199 0.0754
28 SPIROMETRY ABNORMAL 44 0.0736
29 MITE ALLERGY 47 0.0718
30 COLONIC PSEUDO-OBSTRUCTION 20 0.0717
31 CREATININE RENAL CLEARANCE DECREASED 284 0.0709
32 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
33 PROCTITIS 193 0.0688
34 CHRONIC SINUSITIS 256 0.0681
35 MACULAR DEGENERATION 787 0.0658
36 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 47 0.0641
37 HYPERPHOSPHATAEMIA 135 0.0627
38 LEUKOPLAKIA 15 0.0612
39 BLOOD PHOSPHORUS INCREASED 156 0.0571
40 MYCOTIC ALLERGY 47 0.0550
41 TOTAL LUNG CAPACITY DECREASED 85 0.0532
42 HYPOMANIA 185 0.0503
43 JAUNDICE CHOLESTATIC 176 0.0498
44 DUST ALLERGY 47 0.0479
45 PNEUMOCOCCAL INFECTION 24 0.0405
46 PLEURITIC PAIN 95 0.0344
47 CONJUNCTIVITIS ALLERGIC 49 0.0331
48 INTESTINAL PSEUDO-OBSTRUCTION 29 0.0330
49 OROMANDIBULAR DYSTONIA 24 0.0329
50 LUNG OPACITY 85 0.0322
51 NEURITIS 49 0.0317
52 RESPIRATORY SYMPTOM 84 0.0295
53 DYSPRAXIA 16 0.0284
54 BLOOD CALCIUM DECREASED 302 0.0268
55 IGA NEPHROPATHY 44 0.0265
56 BRONCHIECTASIS 178 0.0264
57 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
58 PLICATED TONGUE 12 0.0252
59 RHINITIS ALLERGIC 111 0.0249
60 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 49 0.0240
61 APPENDICITIS 217 0.0232
62 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 117 0.0231
63 ORTHOSTATIC HYPOTENSION 398 0.0228
64 IRON DEFICIENCY 102 0.0227
65 JUVENILE IDIOPATHIC ARTHRITIS 54 0.0221
66 BLOOD URIC ACID INCREASED 126 0.0218
67 NASAL POLYPS 107 0.0217
68 SARCOIDOSIS 103 0.0217
69 SCHIZOPHRENIA 251 0.0206
70 HYPOPHOSPHATAEMIA 151 0.0204
71 HYPORESPONSIVE TO STIMULI 23 0.0196
72 AORTIC STENOSIS 66 0.0189
73 MYASTHENIA GRAVIS 153 0.0189
74 VENTRICULAR FIBRILLATION 210 0.0189
75 VAGINAL DISCHARGE 189 0.0187
76 NEPHROGENIC ANAEMIA 86 0.0185
77 NORMOCHROMIC NORMOCYTIC ANAEMIA 55 0.0183
78 REDUCED FACIAL EXPRESSION 17 0.0167
79 PARAESTHESIA ORAL 238 0.0165
80 HYPERPARATHYROIDISM SECONDARY 41 0.0163
81 ORAL CANDIDIASIS 215 0.0163
82 RENAL FUNCTION TEST ABNORMAL 74 0.0159
83 CARDIOGENIC SHOCK 225 0.0157
84 FORCED EXPIRATORY VOLUME DECREASED 44 0.0155
85 HYPOGONADISM 15 0.0148
86 SLOW RESPONSE TO STIMULI 18 0.0139
87 SEDATION 354 0.0135
88 BLOOD CALCIUM INCREASED 117 0.0133
89 EFFUSION 18 0.0132
90 CARDIAC MURMUR 113 0.0130
91 RALES 75 0.0129
92 ASPIRATION 134 0.0122
93 END STAGE RENAL DISEASE 223 0.0122
94 TROPONIN INCREASED 90 0.0118
95 BENIGN PROSTATIC HYPERPLASIA 60 0.0116
96 REBOUND ACID HYPERSECRETION 33 0.0109
97 RESPIRATORY DEPRESSION 133 0.0108
98 BREATH SOUNDS ABNORMAL 53 0.0107
99 OBSTRUCTIVE AIRWAYS DISORDER 116 0.0104
100 ON AND OFF PHENOMENON 55 0.0099
101 ARTERIOSCLEROSIS CORONARY ARTERY 64 0.0097
102 MUTISM 14 0.0096
103 COGNITIVE DISORDER 450 0.0096
104 PULMONARY ALVEOLAR HAEMORRHAGE 54 0.0096
105 TONGUE DRY 13 0.0096
106 MULTIPLE ORGAN DYSFUNCTION SYNDROME 264 0.0093
107 ORAL MUCOSAL EXFOLIATION 14 0.0092
108 ASCITES 270 0.0092
109 NEUROLOGICAL SYMPTOM 52 0.0091
110 NEURALGIA 219 0.0090
111 CHOLELITHIASIS 289 0.0088
112 EXCESSIVE EYE BLINKING 13 0.0088
113 FULL BLOOD COUNT ABNORMAL 92 0.0087
114 MICTURITION URGENCY 98 0.0086
115 HYPERLIPIDAEMIA 102 0.0085
116 DEPRESSED LEVEL OF CONSCIOUSNESS 336 0.0085
117 BLOOD TEST ABNORMAL 117 0.0083
118 PRODUCT MONITORING ERROR 12 0.0083
119 HEPATOTOXICITY 185 0.0083
120 SEBORRHOEIC KERATOSIS 12 0.0083
121 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 141 0.0082
122 BACTERIAL INFECTION 153 0.0082
123 CLOSTRIDIUM TEST POSITIVE 18 0.0082
124 ANTICHOLINERGIC SYNDROME 13 0.0082
125 PROCEDURAL PAIN 224 0.0081
126 NEUROGENIC BLADDER 17 0.0080
127 LUNG NEOPLASM 34 0.0080
128 FREQUENT BOWEL MOVEMENTS 215 0.0080
129 BLOOD BILIRUBIN INCREASED 213 0.0079
130 ARTERIOSCLEROSIS 74 0.0079
131 SPUTUM DISCOLOURED 70 0.0074
132 HYPONATRAEMIA 399 0.0071
133 GLOSSITIS 25 0.0070
134 STOMA SITE ERYTHEMA 13 0.0070
135 PSYCHOTIC DISORDER 203 0.0069
136 PULMONARY FIBROSIS 131 0.0068
137 CONSTIPATION 1483 0.0068
138 ULCER 108 0.0068
139 SUBILEUS 14 0.0067
140 HYPOXIA 234 0.0066
141 LARGE INTESTINAL ULCER 18 0.0066
142 DECUBITUS ULCER 54 0.0066
143 MONOCYTE COUNT INCREASED 24 0.0066
144 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
145 COLITIS 241 0.0064
146 FAILURE TO THRIVE 33 0.0063
147 ATELECTASIS 61 0.0063
148 JUGULAR VEIN THROMBOSIS 11 0.0062
149 PULMONARY MASS 91 0.0061
150 METABOLIC ENCEPHALOPATHY 18 0.0060
151 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 312 0.0060
152 GOUT 107 0.0060
153 RECTAL HAEMORRHAGE 254 0.0059
154 LISTLESS 19 0.0058
155 HEPARIN-INDUCED THROMBOCYTOPENIA 28 0.0057
156 UROSEPSIS 52 0.0056
157 BALANCE DISORDER 480 0.0055
158 HOSTILITY 14 0.0055
159 CANCER PAIN 14 0.0055
160 MOBILITY DECREASED 380 0.0053
161 HYPERCHOLESTEROLAEMIA 51 0.0053
162 WOUND COMPLICATION 18 0.0052
163 TRANSAMINASES INCREASED 115 0.0052
164 LYMPHOCYTOSIS 11 0.0051
165 FAECALOMA 28 0.0051
166 HAEMOPTYSIS 141 0.0050
167 PARESIS 11 0.0049
168 BLADDER DISORDER 49 0.0049
169 ILEUS PARALYTIC 22 0.0049
170 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
171 COLITIS ISCHAEMIC 33 0.0049
172 LIVER FUNCTION TEST INCREASED 105 0.0049
173 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
174 TONGUE DISCOLOURATION 21 0.0048
175 STOMA SITE DISCHARGE 13 0.0047
176 NON-CARDIAC CHEST PAIN 15 0.0047
177 SMALL INTESTINAL OBSTRUCTION 58 0.0047
178 ESCHERICHIA BACTERAEMIA 11 0.0047
179 GASTROINTESTINAL MOTILITY DISORDER 25 0.0047
180 AORTIC ARTERIOSCLEROSIS 12 0.0047
181 COLITIS ULCERATIVE 207 0.0046
182 HAEMATOCHEZIA 253 0.0046
183 VASCULITIS 53 0.0045
184 BLOOD ALBUMIN DECREASED 36 0.0045
185 PRODUCT PRESCRIBING ERROR 108 0.0045
186 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 321 0.0045
187 CHRONIC KIDNEY DISEASE 340 0.0045
188 OBESITY 71 0.0045
189 FRUSTRATION TOLERANCE DECREASED 36 0.0045
190 NOCTURIA 54 0.0044
191 CLUMSINESS 12 0.0044
192 CATHETER SITE HAEMORRHAGE 11 0.0044
193 OSTEITIS 11 0.0044
194 IMMOBILE 19 0.0043
195 FREEZING PHENOMENON 16 0.0043
196 SEPSIS 482 0.0043
197 TENDERNESS 45 0.0043
198 LUNG CONSOLIDATION 12 0.0043
199 ENDOTRACHEAL INTUBATION 12 0.0043
200 DYSCHEZIA 13 0.0043
201 NEUTROPHIL COUNT INCREASED 43 0.0042
202 GENERAL PHYSICAL HEALTH DETERIORATION 480 0.0041
203 WHEEZING 246 0.0041
204 PNEUMONIA ASPIRATION 103 0.0041
205 LUMBAR SPINAL STENOSIS 12 0.0041
206 LOCALISED OEDEMA 19 0.0041
207 INFUSION RELATED REACTION 272 0.0041
208 GAMBLING DISORDER 11 0.0041
209 AZOTAEMIA 16 0.0040
210 ACUTE RESPIRATORY FAILURE 77 0.0040
211 PLEURAL EFFUSION 242 0.0040
212 NODULE 51 0.0039
213 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
214 ECONOMIC PROBLEM 59 0.0039
215 HYPERURICAEMIA 16 0.0039
216 BONE LESION 14 0.0039
217 ABDOMINAL DISTENSION 402 0.0038
218 RESPIRATORY RATE DECREASED 12 0.0038
219 MENTAL STATUS CHANGES 106 0.0038
220 FOREIGN BODY 15 0.0037
221 NECROTISING FASCIITIS 13 0.0037
222 ANAEMIA 701 0.0037
223 BLOOD CREATININE INCREASED 238 0.0036
224 CRANIOCEREBRAL INJURY 11 0.0036
225 HYPERNATRAEMIA 18 0.0036
226 SELF INJURIOUS BEHAVIOUR 11 0.0036
227 PROSTATE CANCER METASTATIC 12 0.0036
228 PETIT MAL EPILEPSY 18 0.0035
229 JOINT INJURY 75 0.0035
230 HYPOTENSION 701 0.0035
231 FEELING COLD 97 0.0035
232 CORONARY ARTERY DISEASE 105 0.0035
233 RENAL TUBULAR NECROSIS 34 0.0035
234 HYPOKALAEMIA 159 0.0034
235 HOSPICE CARE 34 0.0034
236 MUSCLE SPASTICITY 42 0.0034
237 HYPOVOLAEMIA 20 0.0034
238 SPINAL OSTEOARTHRITIS 30 0.0034
239 RENAL FAILURE CHRONIC 26 0.0034
240 UNRESPONSIVE TO STIMULI 87 0.0034
241 LEUKOCYTOSIS 61 0.0034
242 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
243 DYSARTHRIA 126 0.0033
244 BLOOD CHOLESTEROL INCREASED 156 0.0033
245 GASTROOESOPHAGEAL REFLUX DISEASE 269 0.0033
246 HYPOVOLAEMIC SHOCK 16 0.0033
247 SPINAL CORD COMPRESSION 13 0.0033
248 URINARY RETENTION 110 0.0033
249 ANXIETY DISORDER 11 0.0033
250 ABDOMINAL PAIN 762 0.0033
251 PROCTALGIA 21 0.0033
252 PELVIC FRACTURE 25 0.0032
253 UPPER RESPIRATORY TRACT INFECTION 148 0.0032
254 OEDEMA PERIPHERAL 390 0.0032
255 LOWER RESPIRATORY TRACT INFECTION 145 0.0032
256 PROTEIN TOTAL DECREASED 12 0.0032
257 ODYNOPHAGIA 19 0.0032
258 MALNUTRITION 35 0.0031
259 PULMONARY EMBOLISM 297 0.0031
260 GINGIVAL DISORDER 12 0.0031
261 DEMENTIA 87 0.0031
262 ANAL INCONTINENCE 28 0.0031
263 DELIRIUM 107 0.0031
264 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
265 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
266 ENCEPHALOPATHY 75 0.0031
267 ABSCESS LIMB 13 0.0030
268 RESPIRATION ABNORMAL 21 0.0030
269 IRON DEFICIENCY ANAEMIA 28 0.0030
270 SLEEP DISORDER 214 0.0030
271 CEREBRAL ATROPHY 12 0.0030
272 DYSPEPSIA 295 0.0030
273 FLUID INTAKE REDUCED 15 0.0030
274 ACUTE KIDNEY INJURY 458 0.0030
275 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
276 GRANULOCYTOPENIA 17 0.0030
277 DIVERTICULUM INTESTINAL 13 0.0030
278 PRESYNCOPE 72 0.0030
279 HAEMORRHAGIC ANAEMIA 13 0.0030
280 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 50 0.0029
281 GINGIVAL SWELLING 13 0.0029
282 PNEUMONIA BACTERIAL 27 0.0029
283 PERIPHERAL ISCHAEMIA 12 0.0029
284 HEPATIC ENZYME INCREASED 200 0.0029
285 THROMBOSIS 235 0.0029
286 CACHEXIA 15 0.0029
287 DRUG DIVERSION 18 0.0029
288 CATHETER SITE INFECTION 11 0.0029
289 SPINAL STENOSIS 12 0.0029
290 UPPER GASTROINTESTINAL HAEMORRHAGE 48 0.0029
291 MUSCLE RIGIDITY 34 0.0028
292 INTERNATIONAL NORMALISED RATIO INCREASED 81 0.0028
293 INCONTINENCE 30 0.0028
294 HYPERVOLAEMIA 14 0.0028
295 HYPOALBUMINAEMIA 22 0.0028
296 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
297 FAECES HARD 11 0.0028
298 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
299 TEARFULNESS 12 0.0028
300 PNEUMONIA FUNGAL 11 0.0028
301 INTENTIONAL PRODUCT MISUSE 244 0.0028
302 HEPATIC LESION 12 0.0028
303 HYPOTHYROIDISM 88 0.0028
304 ORAL DISORDER 20 0.0027
305 HAEMATOCRIT DECREASED 54 0.0027
306 PERIPHERAL VASCULAR DISORDER 14 0.0027
307 IMPAIRED GASTRIC EMPTYING 37 0.0027
308 FEBRILE NEUTROPENIA 180 0.0027
309 TRISMUS 14 0.0027
310 BRADYKINESIA 16 0.0027
311 OSTEOPENIA 41 0.0027
312 APLASTIC ANAEMIA 14 0.0027
313 RENAL FAILURE 353 0.0027
314 TRICUSPID VALVE INCOMPETENCE 21 0.0026
315 ATRIAL FLUTTER 21 0.0026
316 HYPOKINESIA 38 0.0026
317 COMPRESSION FRACTURE 14 0.0026
318 DIABETES MELLITUS 199 0.0026
319 QUALITY OF LIFE DECREASED 35 0.0026
320 LUNG INFILTRATION 23 0.0026
321 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
322 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
323 SCOLIOSIS 16 0.0026
324 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
325 BLOOD PROLACTIN INCREASED 12 0.0025
326 HYPOPHAGIA 65 0.0025
327 SPINAL COMPRESSION FRACTURE 21 0.0025
328 GENERAL SYMPTOM 19 0.0025
329 ENDOCARDITIS 13 0.0025
330 URINARY INCONTINENCE 75 0.0025
331 LUNG NEOPLASM MALIGNANT 104 0.0025
332 TOXICITY TO VARIOUS AGENTS 425 0.0025
333 FALL 838 0.0025
334 GINGIVAL PAIN 20 0.0025
335 PROTHROMBIN TIME PROLONGED 15 0.0025
336 PNEUMONIA 811 0.0025
337 TUMOUR LYSIS SYNDROME 22 0.0025
338 WEIGHT FLUCTUATION 26 0.0025
339 ENTEROCOCCAL INFECTION 12 0.0025
340 BLOOD LACTIC ACID INCREASED 13 0.0025
341 NEPHROPATHY 23 0.0025
342 LARGE INTESTINE PERFORATION 17 0.0024
343 POLYP 16 0.0024
344 METASTASES TO BONE 40 0.0024
345 DRY MOUTH 197 0.0024
346 TACHYPNOEA 33 0.0024
347 RENAL INJURY 72 0.0024
348 BLOOD ALKALINE PHOSPHATASE INCREASED 60 0.0024
349 RESPIRATORY FAILURE 175 0.0024
350 ANHEDONIA 63 0.0024
351 CYTOKINE RELEASE SYNDROME 48 0.0024
352 DIVERTICULUM 17 0.0024
353 GROIN PAIN 21 0.0024
354 SKIN LACERATION 26 0.0024
355 MITRAL VALVE INCOMPETENCE 27 0.0024
356 HYPOMAGNESAEMIA 33 0.0024
357 PATHOLOGICAL FRACTURE 12 0.0024
358 LUNG DISORDER 115 0.0023
359 TRANSIENT ISCHAEMIC ATTACK 79 0.0023
360 ILEUS 29 0.0023
361 MOUTH HAEMORRHAGE 17 0.0023
362 MYOPATHY 20 0.0023
363 ASPARTATE AMINOTRANSFERASE INCREASED 123 0.0023
364 HICCUPS 19 0.0023
365 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
366 HAEMATEMESIS 58 0.0023
367 HYDRONEPHROSIS 17 0.0023
368 URINARY TRACT INFECTION 386 0.0023
369 CHOLANGITIS 14 0.0023
370 HAEMORRHOIDS 44 0.0023
371 SPEECH DISORDER 118 0.0022
372 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
373 CARDIOVASCULAR DISORDER 57 0.0022
374 PRODUCTIVE COUGH 107 0.0022
375 DRUG ABUSE 186 0.0022
376 DIABETIC NEUROPATHY 11 0.0022
377 BOWEL MOVEMENT IRREGULARITY 17 0.0022
378 PYREXIA 768 0.0022
379 BLOOD UREA INCREASED 37 0.0022
380 BLOOD LACTATE DEHYDROGENASE INCREASED 35 0.0022
381 RENAL FAILURE ACUTE 93 0.0022
382 SWELLING 205 0.0022
383 RIB FRACTURE 45 0.0022
384 INTESTINAL ISCHAEMIA 12 0.0022
385 KLEBSIELLA INFECTION 11 0.0022
386 TORSADE DE POINTES 17 0.0022
387 SUBDURAL HAEMATOMA 31 0.0022
388 SEPTIC SHOCK 94 0.0022
389 LYMPHOCYTE COUNT DECREASED 38 0.0021
390 PNEUMOTHORAX 34 0.0021
391 DEVICE OCCLUSION 30 0.0021
392 GASTRITIS 56 0.0021
393 CELLULITIS 107 0.0021
394 INTESTINAL OBSTRUCTION 80 0.0021
395 VOMITING 997 0.0021
396 COVID-19 PNEUMONIA 25 0.0021
397 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
398 CARDIOMEGALY 26 0.0021
399 SENSORY LOSS 17 0.0021
400 DRUG INTERACTION 334 0.0021
401 NEUTROPENIC SEPSIS 15 0.0021
402 HERPES VIRUS INFECTION 12 0.0021
403 CONDITION AGGRAVATED 626 0.0021
404 HEMIPLEGIA 17 0.0020
405 MUSCULOSKELETAL STIFFNESS 179 0.0020
406 ECCHYMOSIS 14 0.0020
407 DIPLOPIA 53 0.0020
408 BRUXISM 11 0.0020
409 OXYGEN SATURATION DECREASED 114 0.0020
410 FLANK PAIN 19 0.0020
411 BACTERAEMIA 24 0.0020
412 HYDROCEPHALUS 11 0.0020
413 HAEMATURIA 68 0.0020
414 ELECTROLYTE IMBALANCE 23 0.0020
415 STEVENS-JOHNSON SYNDROME 44 0.0020
416 AFFECT LABILITY 19 0.0020
417 BLOOD SODIUM DECREASED 37 0.0020
418 INTESTINAL PERFORATION 22 0.0020
419 HEAD INJURY 62 0.0020
420 TACHYCARDIA 174 0.0020
421 TERMINAL STATE 13 0.0019
422 SOMNOLENCE 389 0.0019
423 SENSORY DISTURBANCE 31 0.0019
424 HIP FRACTURE 62 0.0019
425 PRE-EXISTING CONDITION IMPROVED 12 0.0019
426 MAJOR DEPRESSION 14 0.0019
427 ASTHMA 215 0.0019
428 BEDRIDDEN 25 0.0019
429 SPINAL DISORDER 18 0.0019
430 DYSKINESIA 77 0.0019
431 DRUG INTOLERANCE 183 0.0019
432 JOINT EFFUSION 13 0.0019
433 HYPERKALAEMIA 66 0.0019
434 HAEMORRHAGE INTRACRANIAL 28 0.0019
435 AUTOIMMUNE HEPATITIS 13 0.0019
436 BRADYCARDIA 99 0.0019
437 BONE DISORDER 34 0.0019
438 SUBARACHNOID HAEMORRHAGE 19 0.0019
439 HYPERCALCAEMIA 23 0.0019
440 RIGHT VENTRICULAR FAILURE 13 0.0019
441 DEHYDRATION 247 0.0018
442 RESPIRATORY DISTRESS 51 0.0018
443 HEPATITIS ACUTE 12 0.0018
444 MYOCLONUS 22 0.0018
445 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
446 LETHARGY 106 0.0018
447 PULMONARY OEDEMA 82 0.0018
448 URINE OUTPUT DECREASED 16 0.0018
449 LIPASE INCREASED 14 0.0018
450 GANGRENE 11 0.0018
451 ESCHERICHIA INFECTION 15 0.0018
452 MUSCULOSKELETAL CHEST PAIN 28 0.0018
453 INGUINAL HERNIA 11 0.0018
454 CONCUSSION 14 0.0018
455 RESPIRATORY RATE INCREASED 16 0.0018
456 PAIN 1103 0.0018
457 BRAIN INJURY 18 0.0018
458 APHONIA 25 0.0018
459 CYSTITIS 57 0.0018
460 WEIGHT DECREASED 498 0.0018
461 INFUSION SITE ERYTHEMA 15 0.0018
462 POSTOPERATIVE WOUND INFECTION 12 0.0018
463 ACUTE MYOCARDIAL INFARCTION 52 0.0018
464 RENAL CYST 14 0.0018
465 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
466 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
467 MIOSIS 14 0.0017
468 DYSPHONIA 102 0.0017
469 HAEMOGLOBIN DECREASED 179 0.0017
470 LARGE INTESTINE POLYP 12 0.0017
471 BLOOD POTASSIUM DECREASED 52 0.0017
472 NAUSEA 1366 0.0017
473 CARDIAC ARREST 142 0.0017
474 POOR QUALITY SLEEP 37 0.0017
475 MASS 24 0.0017
476 ABNORMAL FAECES 14 0.0017
477 LACERATION 16 0.0017
478 GASTROINTESTINAL HAEMORRHAGE 142 0.0017
479 DEEP VEIN THROMBOSIS 110 0.0017
480 GASTRIC ULCER 32 0.0017
481 TREMOR 279 0.0017
482 EOSINOPHIL COUNT INCREASED 14 0.0017
483 OSTEOARTHRITIS 71 0.0017
484 SEROTONIN SYNDROME 32 0.0017
485 SWOLLEN TONGUE 52 0.0017
486 CARDIAC FAILURE ACUTE 11 0.0016
487 RED BLOOD CELL COUNT DECREASED 47 0.0016
488 WOUND INFECTION 18 0.0016
489 MUCOSAL INFLAMMATION 43 0.0016
490 PSEUDOMONAS INFECTION 14 0.0016
491 PETECHIAE 17 0.0016
492 OSTEOPOROSIS 67 0.0016
493 CONFUSIONAL STATE 263 0.0016
494 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
495 DEVICE RELATED INFECTION 25 0.0016
496 ATRIAL FIBRILLATION 158 0.0016
497 PLASMA CELL MYELOMA 63 0.0016
498 DYSPHAGIA 153 0.0016
499 HALLUCINATION, VISUAL 34 0.0016
500 OSTEOMYELITIS 29 0.0016
501 ASTHENIA 599 0.0016
502 PULMONARY HYPERTENSION 33 0.0016
503 LIVER FUNCTION TEST ABNORMAL 46 0.0016
504 APATHY 23 0.0016
505 MYOCARDITIS 18 0.0016
506 FACIAL PAIN 14 0.0016
507 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
508 DUODENAL ULCER 11 0.0016
509 RHABDOMYOLYSIS 65 0.0016
510 HALLUCINATION 117 0.0016
511 EATING DISORDER 33 0.0015
512 SKIN ULCER 40 0.0015
513 LIMB INJURY 42 0.0015
514 HIATUS HERNIA 20 0.0015
515 APNOEA 12 0.0015
516 PRODUCT USE IN UNAPPROVED INDICATION 382 0.0015
517 HEMIPARESIS 26 0.0015
518 EXOSTOSIS 14 0.0015
519 SEIZURE 177 0.0015
520 HYPOCALCAEMIA 29 0.0015
521 GASTROINTESTINAL INFLAMMATION 12 0.0015
522 SKIN LESION 42 0.0015
523 OEDEMA 83 0.0015
524 INCREASED TENDENCY TO BRUISE 14 0.0015
525 PANCREATITIS ACUTE 34 0.0015
526 PERSONALITY CHANGE 14 0.0015
527 CARDIO-RESPIRATORY ARREST 63 0.0015
528 CARDIAC FAILURE CONGESTIVE 121 0.0015
529 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
530 MELAENA 33 0.0015
531 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
532 DISORIENTATION 59 0.0015
533 LIVER DISORDER 66 0.0015
534 DYSPNOEA 841 0.0015
535 WHITE BLOOD CELL COUNT INCREASED 57 0.0015
536 FEMUR FRACTURE 46 0.0015
537 SINUS TACHYCARDIA 21 0.0015
538 TOOTH ABSCESS 15 0.0015
539 PNEUMONITIS 40 0.0015
540 PARALYSIS 21 0.0015
541 TOOTH FRACTURE 16 0.0014
542 SINUS BRADYCARDIA 14 0.0014
543 IRRITABLE BOWEL SYNDROME 31 0.0014
544 EMBOLISM 12 0.0014
545 HAEMODYNAMIC INSTABILITY 11 0.0014
546 FLUID OVERLOAD 21 0.0014
547 PULMONARY CONGESTION 19 0.0014
548 COAGULOPATHY 24 0.0014
549 HYPERTENSION 305 0.0014
550 VITAMIN D DEFICIENCY 14 0.0014
551 COORDINATION ABNORMAL 20 0.0014
552 TRANSFUSION 15 0.0014
553 PANCYTOPENIA 80 0.0014
554 ORAL PAIN 32 0.0014
555 METASTASES TO LIVER 25 0.0014
556 RESPIRATORY TRACT INFECTION 37 0.0014
557 JOINT DISLOCATION 15 0.0014
558 TARDIVE DYSKINESIA 40 0.0014
559 SUDDEN DEATH 15 0.0014
560 LYMPHADENOPATHY 50 0.0014
561 DIALYSIS 20 0.0014
562 HAEMORRHAGIC STROKE 11 0.0014
563 SALIVARY HYPERSECRETION 14 0.0014
564 METASTASES TO CENTRAL NERVOUS SYSTEM 18 0.0014
565 THROMBOCYTOPENIA 156 0.0014
566 FLATULENCE 79 0.0014
567 GASTROENTERITIS VIRAL 25 0.0014
568 FAECES DISCOLOURED 30 0.0014
569 ABSCESS 22 0.0014
570 MOUTH ULCERATION 29 0.0014
571 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
572 FRACTURE 26 0.0014
573 FOOT FRACTURE 26 0.0014
574 ERYTHEMA 281 0.0014
575 RHINITIS 11 0.0014
576 MENTAL IMPAIRMENT 33 0.0014
577 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
578 CIRCULATORY COLLAPSE 23 0.0013
579 MUSCULAR WEAKNESS 153 0.0013
580 CHOLECYSTITIS 16 0.0013
581 EAR PAIN 26 0.0013
582 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 11 0.0013
583 PHARYNGEAL SWELLING 13 0.0013
584 HEPATIC FAILURE 40 0.0013
585 INTERVERTEBRAL DISC PROTRUSION 29 0.0013
586 LIP DRY 12 0.0013
587 HYPOGLYCAEMIA 64 0.0013
588 HYPERGLYCAEMIA 48 0.0013
589 SLEEP APNOEA SYNDROME 25 0.0013
590 OFF LABEL USE 1145 0.0013
591 DYSSTASIA 38 0.0013
592 DYSPNOEA EXERTIONAL 49 0.0013
593 NEUTROPHIL COUNT DECREASED 53 0.0013
594 DECREASED APPETITE 302 0.0013
595 METASTASES TO LUNG 15 0.0013
596 C-REACTIVE PROTEIN INCREASED 47 0.0013
597 FACIAL PARALYSIS 11 0.0013
598 HEART RATE IRREGULAR 29 0.0013
599 ACUTE MYELOID LEUKAEMIA 20 0.0013
600 FEEDING DISORDER 26 0.0013
601 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
602 SKIN HYPERPIGMENTATION 11 0.0013
603 ANURIA 11 0.0013
604 DYSURIA 47 0.0013
605 GASTROINTESTINAL PAIN 14 0.0013
606 TEMPERATURE INTOLERANCE 13 0.0013
607 HYPERTENSIVE CRISIS 14 0.0013
608 EOSINOPHILIA 22 0.0013
609 PERITONITIS 26 0.0013
610 PERICARDIAL EFFUSION 29 0.0013
611 ABDOMINAL PAIN UPPER 258 0.0013
612 PURPURA 11 0.0012
613 STAPHYLOCOCCAL INFECTION 41 0.0012
614 STATUS EPILEPTICUS 14 0.0012
615 PERIPHERAL COLDNESS 17 0.0012
616 GASTROENTERITIS 18 0.0012
617 CARDIAC FAILURE 99 0.0012
618 ISCHAEMIC STROKE 22 0.0012
619 CHOKING 24 0.0012
620 APHASIA 37 0.0012
621 LUNG INFECTION 19 0.0012
622 EJECTION FRACTION DECREASED 19 0.0012
623 NEUROPATHY PERIPHERAL 116 0.0012
624 SYNCOPE 122 0.0012
625 PARANOIA 21 0.0012
626 CARDIOMYOPATHY 18 0.0012
627 TYPE 2 DIABETES MELLITUS 41 0.0012
628 TOOTHACHE 22 0.0012
629 SKIN HAEMORRHAGE 18 0.0012
630 TOOTH INFECTION 16 0.0012
631 OSTEONECROSIS OF JAW 30 0.0012
632 PATHOGEN RESISTANCE 11 0.0012
633 ALANINE AMINOTRANSFERASE INCREASED 74 0.0012
634 STOMATITIS 73 0.0012
635 JOINT RANGE OF MOTION DECREASED 16 0.0012
636 EMPHYSEMA 12 0.0012
637 BRAIN OEDEMA 15 0.0012
638 ABNORMAL BEHAVIOUR 47 0.0012
639 MALAISE 520 0.0012
640 BONE DENSITY DECREASED 37 0.0012
641 DENTAL CARIES 13 0.0012
642 RESTLESSNESS 43 0.0012
643 LIP SWELLING 39 0.0012
644 GAIT DISTURBANCE 224 0.0012
645 SCAR 20 0.0012
646 SKIN INFECTION 13 0.0012
647 DELUSION 18 0.0012
648 BLISTER 65 0.0012
649 MULTI-ORGAN FAILURE 20 0.0012
650 VENTRICULAR EXTRASYSTOLES 12 0.0012
651 NEPHROLITHIASIS 53 0.0012
652 BURSITIS 14 0.0012
653 BACK PAIN 268 0.0012
654 NIGHT SWEATS 37 0.0011
655 DRUG LEVEL INCREASED 19 0.0011
656 LOWER LIMB FRACTURE 22 0.0011
657 PLATELET COUNT DECREASED 122 0.0011
658 CYTOPENIA 14 0.0011
659 LACTIC ACIDOSIS 37 0.0011
660 MYOCARDIAL ISCHAEMIA 13 0.0011
661 GASTROINTESTINAL DISORDER 102 0.0011
662 COLD SWEAT 20 0.0011
663 DIZZINESS POSTURAL 11 0.0011
664 NEUTROPENIA 154 0.0011
665 GENERALISED OEDEMA 14 0.0011
666 BONE LOSS 17 0.0011
667 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
668 GALLBLADDER DISORDER 20 0.0011
669 CEREBRAL HAEMORRHAGE 40 0.0011
670 CHEST PAIN 205 0.0011
671 BLOOD URINE PRESENT 21 0.0011
672 CHILLS 129 0.0011
673 OESOPHAGITIS 12 0.0011
674 PERITONITIS BACTERIAL 11 0.0011
675 CYANOSIS 17 0.0011
676 MOTOR DYSFUNCTION 11 0.0011
677 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
678 AGITATION 79 0.0011
679 PLATELET COUNT INCREASED 14 0.0011
680 ADRENAL INSUFFICIENCY 13 0.0011
681 COVID-19 187 0.0011
682 MALIGNANT NEOPLASM PROGRESSION 109 0.0011
683 METABOLIC ACIDOSIS 34 0.0011
684 POLLAKIURIA 44 0.0011
685 VERTIGO 64 0.0010
686 CONTUSION 101 0.0010
687 BLOOD POTASSIUM INCREASED 17 0.0010
688 ANGINA PECTORIS 30 0.0010
689 AMNESIA 68 0.0010
690 RESTLESS LEGS SYNDROME 19 0.0010
691 SHOCK 24 0.0010
692 AGEUSIA 26 0.0010
693 POST PROCEDURAL COMPLICATION 20 0.0010
694 ANKLE FRACTURE 16 0.0010
695 HEADACHE 648 0.0010
696 MANIA 17 0.0010
697 VENTRICULAR TACHYCARDIA 17 0.0010
698 BODY TEMPERATURE INCREASED 21 0.0010
699 ANXIETY 292 0.0010
700 HYPERHIDROSIS 132 0.0010
701 SPLENOMEGALY 12 0.0010
702 BREAST CANCER METASTATIC 11 0.0010
703 SPINAL PAIN 12 0.0010
704 RENAL IMPAIRMENT 86 0.0010
705 SEXUAL DYSFUNCTION 12 0.0010
706 BLOOD PRESSURE DECREASED 68 0.0010
707 HEPATIC STEATOSIS 19 0.0010
708 COUGH 285 0.0010
709 EPISTAXIS 76 0.0010
710 DRUG INEFFECTIVE 1336 0.0010
711 TOOTH LOSS 21 0.0010
712 EXTRAPYRAMIDAL DISORDER 25 0.0010
713 IMMUNODEFICIENCY 15 0.0010
714 DEPRESSION 225 0.0010
715 GAIT INABILITY 33 0.0010
716 NO THERAPEUTIC RESPONSE 12 0.0010
717 FLUID RETENTION 50 0.0010
718 RESPIRATORY ARREST 27 0.0010
719 LIVER INJURY 24 0.0010
720 ORAL HERPES 19 0.0010
721 DRUG DEPENDENCE 156 0.0010
722 WHITE BLOOD CELL COUNT DECREASED 105 0.0010
723 HAEMATOMA 25 0.0010
724 TOOTH EXTRACTION 12 0.0010
725 MUSCLE TWITCHING 22 0.0010
726 DRUG TOXICITY 13 0.0010
727 PAIN IN EXTREMITY 281 0.0010
728 PAIN IN JAW 27 0.0010
729 ARRHYTHMIA 45 0.0009
730 NECK PAIN 53 0.0009
731 CANDIDA INFECTION 16 0.0009
732 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
733 BRONCHITIS 70 0.0009
734 CEREBRAL INFARCTION 23 0.0009
735 HEPATIC FUNCTION ABNORMAL 35 0.0009
736 HUNGER 13 0.0009
737 FATIGUE 726 0.0009
738 INFUSION SITE PAIN 12 0.0009
739 CHROMATURIA 21 0.0009
740 DYSTONIA 18 0.0009
741 DISTURBANCE IN ATTENTION 50 0.0009
742 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
743 LOSS OF CONSCIOUSNESS 118 0.0009
744 SEASONAL ALLERGY 13 0.0009
745 HOSPITALISATION 141 0.0009
746 BRONCHOSPASM 13 0.0009
747 CONVULSION 52 0.0009
748 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
749 FIBROMYALGIA 22 0.0009
750 TENDONITIS 14 0.0009
751 HEAD DISCOMFORT 16 0.0009
752 MOVEMENT DISORDER 29 0.0009
753 LEUKOPENIA 45 0.0009
754 MEDICATION ERROR 50 0.0009
755 SKIN DISORDER 30 0.0009
756 TOOTH DISORDER 20 0.0009
757 MYELODYSPLASTIC SYNDROME 13 0.0009
758 THIRST 16 0.0009
759 DEATH 770 0.0009
760 RASH PAPULAR 20 0.0009
761 SKIN DISCOLOURATION 41 0.0009
762 DIARRHOEA 575 0.0009
763 FACE OEDEMA 15 0.0009
764 EYE PAIN 50 0.0009
765 ACUTE HEPATIC FAILURE 12 0.0009
766 MUSCULOSKELETAL PAIN 46 0.0009
767 BLOOD PRESSURE FLUCTUATION 21 0.0009
768 DISCOMFORT 53 0.0009
769 OROPHARYNGEAL PAIN 80 0.0009
770 CONJUNCTIVITIS 16 0.0009
771 ROTATOR CUFF SYNDROME 11 0.0009
772 HEART RATE DECREASED 30 0.0009
773 IMPAIRED HEALING 28 0.0009
774 MENTAL DISORDER 37 0.0008
775 INSURANCE ISSUE 13 0.0008
776 INFECTION 123 0.0008
777 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
778 MOOD SWINGS 27 0.0008
779 INSOMNIA 225 0.0008
780 INJURY 59 0.0008
781 DIABETIC KETOACIDOSIS 20 0.0008
782 PERIPHERAL SWELLING 128 0.0008
783 GLAUCOMA 16 0.0008
784 DISEASE PROGRESSION 98 0.0008
785 ANGER 28 0.0008
786 HEART RATE INCREASED 82 0.0008
787 SUICIDE ATTEMPT 50 0.0008
788 PRODUCT DOSE OMISSION ISSUE 242 0.0008
789 MEMORY IMPAIRMENT 113 0.0008
790 HALLUCINATION, AUDITORY 13 0.0008
791 MUSCLE SPASMS 150 0.0008
792 RASH ERYTHEMATOUS 39 0.0008
793 SINUS CONGESTION 11 0.0008
794 PRODUCT USE ISSUE 153 0.0008
795 SWELLING FACE 53 0.0008
796 INFLAMMATION 42 0.0008
797 ILLNESS 83 0.0008
798 COLON CANCER 12 0.0008
799 TREATMENT NONCOMPLIANCE 44 0.0008
800 CEREBROVASCULAR ACCIDENT 136 0.0008
801 SPINAL FRACTURE 16 0.0008
802 ABNORMAL DREAMS 22 0.0008
803 PALPITATIONS 93 0.0008
804 RENAL DISORDER 37 0.0008
805 DIVERTICULITIS 22 0.0008
806 ABDOMINAL DISCOMFORT 133 0.0008
807 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
808 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
809 MULTIPLE FRACTURES 13 0.0008
810 HYPOACUSIS 34 0.0008
811 SKIN CANCER 17 0.0008
812 DIZZINESS 392 0.0008
813 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 141 0.0008
814 CHOLESTASIS 15 0.0008
815 AGGRESSION 39 0.0008
816 EMOTIONAL DISTRESS 94 0.0008
817 NERVOUS SYSTEM DISORDER 24 0.0008
818 HYPOAESTHESIA 115 0.0008
819 DERMATITIS 16 0.0008
820 KNEE ARTHROPLASTY 16 0.0008
821 HYPERTHYROIDISM 11 0.0008
822 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
823 PANCREATITIS 40 0.0008
824 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
825 SCIATICA 12 0.0008
826 BONE PAIN 44 0.0008
827 SKIN EXFOLIATION 63 0.0007
828 HEPATIC CIRRHOSIS 14 0.0007
829 FULL BLOOD COUNT DECREASED 15 0.0007
830 TASTE DISORDER 15 0.0007
831 RASH GENERALISED 19 0.0007
832 BLOOD PRESSURE INCREASED 112 0.0007
833 ABASIA 18 0.0007
834 GASTRIC DISORDER 25 0.0007
835 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
836 MIGRAINE 69 0.0007
837 GLOSSODYNIA 16 0.0007
838 OVERDOSE 154 0.0007
839 LIMB DISCOMFORT 22 0.0007
840 SINUS DISORDER 14 0.0007
841 PARAESTHESIA 111 0.0007
842 BRAIN FOG 11 0.0007
843 PRESCRIBED UNDERDOSE 14 0.0007
844 ANGIOEDEMA 31 0.0007
845 INFLUENZA 78 0.0007
846 PALLOR 19 0.0007
847 MUSCULOSKELETAL DISCOMFORT 12 0.0007
848 TINNITUS 32 0.0007
849 NIGHTMARE 24 0.0007
850 VIRAL INFECTION 23 0.0007
851 DEAFNESS 18 0.0007
852 BLOOD GLUCOSE DECREASED 33 0.0007
853 EYE PRURITUS 23 0.0007
854 PROTEINURIA 13 0.0007
855 EAR INFECTION 18 0.0007
856 RASH MACULO-PAPULAR 15 0.0007
857 CHEST DISCOMFORT 69 0.0007
858 VISION BLURRED 92 0.0007
859 RESPIRATORY DISORDER 20 0.0007
860 THERAPY NON-RESPONDER 30 0.0007
861 THROAT TIGHTNESS 18 0.0007
862 INTENTIONAL PRODUCT USE ISSUE 58 0.0007
863 ERECTILE DYSFUNCTION 17 0.0007
864 CYTOMEGALOVIRUS INFECTION 11 0.0007
865 DRUG RESISTANCE 17 0.0007
866 LOCALISED INFECTION 16 0.0007
867 NEOPLASM PROGRESSION 23 0.0007
868 MYOCARDIAL INFARCTION 115 0.0007
869 MYALGIA 112 0.0007
870 THERAPY INTERRUPTED 47 0.0007
871 WEIGHT INCREASED 147 0.0007
872 CATARACT 39 0.0007
873 EPILEPSY 20 0.0007
874 ARTHRITIS 51 0.0006
875 GYNAECOMASTIA 20 0.0006
876 RASH PRURITIC 35 0.0006
877 THINKING ABNORMAL 12 0.0006
878 DEPRESSED MOOD 34 0.0006
879 PRODUCT PRESCRIBING ISSUE 14 0.0006
880 MULTIPLE SCLEROSIS RELAPSE 44 0.0006
881 CARDIAC DISORDER 60 0.0006
882 DRY EYE 32 0.0006
883 DRUG-INDUCED LIVER INJURY 20 0.0006
884 INTENTIONAL DOSE OMISSION 18 0.0006
885 MUSCULOSKELETAL DISORDER 12 0.0006
886 FUNGAL INFECTION 21 0.0006
887 RASH MACULAR 22 0.0006
888 LACRIMATION INCREASED 19 0.0006
889 INCREASED APPETITE 12 0.0006
890 THERAPY CESSATION 32 0.0006
891 UNEVALUABLE EVENT 47 0.0006
892 ERUCTATION 12 0.0006
893 SKIN FISSURES 12 0.0006
894 BURNING SENSATION 43 0.0006
895 SUICIDAL IDEATION 56 0.0006
896 KIDNEY INFECTION 12 0.0006
897 HERPES ZOSTER 35 0.0006
898 MULTIPLE SCLEROSIS 29 0.0006
899 FEELING HOT 37 0.0006
900 RHINORRHOEA 39 0.0006
901 NASAL CONGESTION 35 0.0006
902 PRODUCT ADMINISTRATION ERROR 12 0.0006
903 SINUSITIS 60 0.0006
904 ARTHRALGIA 243 0.0006
905 ANAPHYLACTIC SHOCK 15 0.0006
906 PRURITUS 223 0.0006
907 LABORATORY TEST ABNORMAL 17 0.0006
908 COMA 27 0.0006
909 HYPERSOMNIA 16 0.0006
910 RASH 242 0.0006
911 ABDOMINAL PAIN LOWER 14 0.0006
912 OSTEONECROSIS 18 0.0005
913 HEPATITIS 14 0.0005
914 ACCIDENTAL OVERDOSE 20 0.0005
915 HAEMORRHAGE 56 0.0005
916 DEVICE DISLOCATION 23 0.0005
917 PANIC ATTACK 19 0.0005
918 EMOTIONAL DISORDER 16 0.0005
919 RETCHING 11 0.0005
920 ADVERSE DRUG REACTION 46 0.0005
921 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
922 WOUND 14 0.0005
923 CRYING 18 0.0005
924 SURGERY 29 0.0005
925 VISUAL IMPAIRMENT 61 0.0005
926 HOT FLUSH 37 0.0005
927 THROAT IRRITATION 22 0.0005
928 FEAR 13 0.0005
929 NEOPLASM MALIGNANT 32 0.0005
930 ANAPHYLACTIC REACTION 26 0.0005
931 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
932 INTENTIONAL OVERDOSE 30 0.0005
933 IRRITABILITY 28 0.0005
934 BLOOD GLUCOSE INCREASED 87 0.0005
935 EYE SWELLING 17 0.0005
936 JOINT SWELLING 55 0.0005
937 JAUNDICE 12 0.0004
938 PAIN OF SKIN 12 0.0004
939 HYPERSENSITIVITY 81 0.0004
940 URTICARIA 73 0.0004
941 GASTRIC CANCER 11 0.0004
942 DYSGEUSIA 32 0.0004
943 ILL-DEFINED DISORDER 26 0.0004
944 VISUAL ACUITY REDUCED 14 0.0004
945 PANCREATIC CARCINOMA 12 0.0004
946 ARTHROPATHY 23 0.0004
947 DRY SKIN 55 0.0004
948 ROAD TRAFFIC ACCIDENT 17 0.0004
949 FEELING ABNORMAL 94 0.0004
950 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
951 NEEDLE ISSUE 11 0.0004
952 NASOPHARYNGITIS 69 0.0004
953 PREMATURE BABY 11 0.0004
954 FLUSHING 37 0.0004
955 DEVICE ISSUE 32 0.0004
956 UNDERDOSE 26 0.0004
957 DRUG WITHDRAWAL SYNDROME 31 0.0004
958 INFLUENZA LIKE ILLNESS 29 0.0004
959 INTERSTITIAL LUNG DISEASE 17 0.0004
960 ECZEMA 18 0.0003
961 INCORRECT DOSE ADMINISTERED 77 0.0003
962 TREATMENT FAILURE 27 0.0003
963 OCULAR HYPERAEMIA 15 0.0003
964 PRODUCT DOSE OMISSION 20 0.0003
965 EXTRA DOSE ADMINISTERED 12 0.0003
966 ALOPECIA 58 0.0003
967 ADVERSE EVENT 27 0.0003
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
969 THERAPEUTIC RESPONSE DECREASED 17 0.0003
970 EYE IRRITATION 16 0.0003
971 NERVOUSNESS 14 0.0003
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
973 DRUG EFFECT DECREASED 13 0.0002
974 RHEUMATOID ARTHRITIS 27 0.0002
975 NO ADVERSE EVENT 43 0.0002
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 48 0.0002
977 INJECTION SITE REACTION 16 0.0002
978 ACNE 17 0.0002
979 PROSTATE CANCER 18 0.0002
980 INJECTION SITE BRUISING 17 0.0002
981 INJECTION SITE PRURITUS 14 0.0002
982 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
983 PRODUCT QUALITY ISSUE 25 0.0002
984 DEVICE MALFUNCTION 12 0.0002
985 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
986 BREAST CANCER 15 0.0002
987 DRUG DOSE OMISSION 25 0.0002
988 INJECTION SITE PAIN 46 0.0001
989 PSORIASIS 17 0.0001
990 INJECTION SITE ERYTHEMA 16 0.0001